Drug interactions of HIV protease inhibitors.
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 20 (2) , 147-169
- https://doi.org/10.2165/00002018-199920020-00005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteersBritish Journal of Clinical Pharmacology, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- RitonavirClinical Pharmacokinetics, 1998
- Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavirBritish Journal of Clinical Pharmacology, 1997
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virusClinical Therapeutics, 1997
- Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2.Sexually Transmitted Infections, 1997
- Drug Interactions in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Current Knowledge and Future Prospects for the Use of HIV Protease InhibitorsDrugs, 1996